146 related articles for article (PubMed ID: 21265466)
1. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects.
Sasongko L; Harahap Y; Prasaja B; Lusthom W; Setiawan EC; Meliala RS; Lipin
Arzneimittelforschung; 2010; 60(12):749-53. PubMed ID: 21265466
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic properties and bioequivalence of two irbesartan/ hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers.
Liu J; Wu L; Hu X; Wu G; Zheng Y; Zhou H; Zhai Y; Zhu M; ShenTu J
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):573-81. PubMed ID: 25828636
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25 mg and 300/12.5 mg film-coated tablets.
Cánovas M; Cabré F; Polonio F
Drug Res (Stuttg); 2014 May; 64(5):257-62. PubMed ID: 24105103
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions.
Tjandrawinata RR; Setiawati E; Yunaidi DA; Simanjuntak R; Santoso ID; Susanto LW
Drug Des Devel Ther; 2013; 7():841-7. PubMed ID: 23990709
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies.
Tutunji LF; Tutunji MF; Alzoubi MI; Khabbas MH; Arida AI
J Pharm Biomed Anal; 2010 Mar; 51(4):985-90. PubMed ID: 20004542
[TBL] [Abstract][Full Text] [Related]
7. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study of two oral formulations of irbesartan 300 mg in healthy volunteers.
Cánovas M; Cabré F; Polonio F
Drug Res (Stuttg); 2014 Jan; 64(1):53-6. PubMed ID: 24048950
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of two rosuvastatin tablet formulations in healthy Indonesian subjects.
Harahap Y; Prasaja B; Azmi F; Lusthom W; Sinandang T; Felicia V; Yusvita LY; Panjaitan LY
Int J Clin Pharmacol Ther; 2016 Mar; 54(3):212-6. PubMed ID: 26073355
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers.
Neves R; Almeida S; Filipe A; Spínola AC; Abolfathi Z; Yritia M; Ortuño J
Arzneimittelforschung; 2008; 58(8):369-75. PubMed ID: 18807576
[TBL] [Abstract][Full Text] [Related]
11. Combination of losartan and hydrochlorothiazide: in vivo bioequivalence.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):611-7. PubMed ID: 15497669
[TBL] [Abstract][Full Text] [Related]
12. Effect of the combination of lisinopril and hydrochlorothiazide on the bioequivalence of tablet formulations.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):605-10. PubMed ID: 15497668
[TBL] [Abstract][Full Text] [Related]
13. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
[TBL] [Abstract][Full Text] [Related]
14. A bioequivalence study of two tamsulosin sustained-release tablets in Indonesian healthy volunteers.
Prasaja B; Harahap Y; Lusthom W; Setiawan EC; Ginting MB; Hardiyanti ; Lipin
Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):109-13. PubMed ID: 21432621
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioavailability of two estazolam tablet formulations in Indonesian healthy volunteers.
Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
Arzneimittelforschung; 2008; 58(10):501-4. PubMed ID: 19025059
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence study of 2 formulations of film-coated tablets containing a fixed dose combination of bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg in healthy subjects.
Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW
Drug Res (Stuttg); 2013 May; 63(5):243-9. PubMed ID: 23539427
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers.
Gascón AR; Cuadrado A; Solinís MA; Hernández RM; Ramírez E; Dalmau R; Pedraz JL
Int J Clin Pharmacol Ther; 2003 Jul; 41(7):309-15. PubMed ID: 12875347
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the bioequivalence of two tablet formulations of enalapril/hydrochlorothiazide after single oral administration to healthy volunteers.
Niopas I; Daftsios AC; Nikolaidis N
Arzneimittelforschung; 2004; 54(3):160-5. PubMed ID: 15112862
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers.
Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
Arzneimittelforschung; 2009; 59(4):191-4. PubMed ID: 19517895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
